Jaguar Health, Inc. SEC filings JAGX
Jaguar Health, Inc. has 1,004 filings in SEC EDGAR's recent list, going back to Jun 16, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 19, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| PRER14A | Filing | Sep 29, 2026 | — |
| EFFECT | Filing | Aug 14, 2026 | — |
| NT 10-Q | Filing | Aug 14, 2026 | Jun 30, 2026 |
| EFFECT | Filing | Jul 24, 2026 | — |
| EFFECT | Filing | Jul 24, 2026 | — |
| D | Filing | Jul 1, 2026 | — |
| D | Filing | Jul 1, 2026 | — |
| NT 10-Q | Filing | May 18, 2026 | Mar 31, 2026 |
| NT 10-K | Filing | Apr 1, 2026 | Dec 31, 2025 |
| EFFECT | Filing | Nov 25, 2025 | — |
| D | Filing | Nov 24, 2025 | — |
| CORRESP | Letter to the SEC | Nov 24, 2025 | — |
| D | Filing | Oct 10, 2025 | — |
| D | Filing | Sep 23, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| CORRESP | Letter to the SEC | Jul 28, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 28, 2025 | — |
| EFFECT | Filing | Jun 27, 2025 | — |
| CORRESP | Letter to the SEC | Jun 25, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2025 | — |
| D | Filing | May 28, 2025 | — |
| EFFECT | Filing | May 7, 2025 | — |
| CORRESP | Letter to the SEC | May 5, 2025 | — |
| CORRESP | Letter to the SEC | Apr 25, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 24, 2025 | — |
| 8-A12B | Filing | Feb 27, 2025 | — |
| EFFECT | Filing | May 1, 2024 | — |
| CORRESP | Letter to the SEC | Apr 29, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 29, 2024 | — |
| D | Filing | Nov 30, 2023 | — |
| D | Filing | May 11, 2023 | — |
| D | Filing | May 11, 2023 | — |
| DEFR14A | Filing | Dec 16, 2022 | — |
| D | Filing | Sep 23, 2022 | — |
| D | Filing | Sep 2, 2022 | — |
| NT 10-Q | Filing | Aug 16, 2022 | Jun 30, 2022 |
| D | Filing | Jul 8, 2022 | — |
| D | Filing | Apr 26, 2022 | — |
| D | Filing | Apr 25, 2022 | — |
| D | Filing | Apr 25, 2022 | — |
| EFFECT | Filing | Dec 3, 2021 | — |
| CORRESP | Letter to the SEC | Dec 1, 2021 | — |
| UPLOAD | Letter from the SEC | Nov 30, 2021 | — |
| NT 10-Q | Filing | Nov 15, 2021 | Sep 30, 2021 |
| D | Filing | Sep 24, 2021 | — |
| EFFECT | Filing | Jun 9, 2021 | — |
| CORRESP | Letter to the SEC | Jun 7, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 4, 2021 | — |
| D | Filing | Mar 26, 2021 | — |
| D | Filing | Feb 4, 2021 | — |
| D | Filing | Feb 4, 2021 | — |
| EFFECT | Filing | Sep 23, 2020 | — |
| CORRESP | Letter to the SEC | Sep 21, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 18, 2020 | — |
| D | Filing | Sep 17, 2020 | — |
| EFFECT | Filing | Jun 25, 2020 | — |
| CORRESP | Letter to the SEC | Jun 23, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 22, 2020 | — |
| PRER14A | Filing | Jun 18, 2020 | — |
| CORRESP | Letter to the SEC | Jun 18, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2020 | — |
| UPLOAD | Letter from the SEC | Jun 17, 2020 | — |
| D | Filing | Jun 5, 2020 | — |
| EFFECT | Filing | Apr 15, 2020 | — |
| EFFECT | Filing | Apr 15, 2020 | — |
| CORRESP | Letter to the SEC | Apr 15, 2020 | — |
| CORRESP | Letter to the SEC | Apr 13, 2020 | — |
| UPLOAD | Letter from the SEC | Apr 10, 2020 | — |
| D | Filing | Apr 8, 2020 | — |
| D | Filing | Apr 7, 2020 | — |
| CORRESP | Letter to the SEC | Apr 6, 2020 | — |
| NT 10-K | Filing | Mar 31, 2020 | Dec 31, 2019 |
| UPLOAD | Letter from the SEC | Feb 4, 2020 | — |
| D | Filing | Jan 6, 2020 | — |
| EFFECT | Filing | Oct 30, 2019 | — |
| CORRESP | Letter to the SEC | Oct 28, 2019 | — |
| CORRESP | Letter to the SEC | Oct 22, 2019 | — |
| UPLOAD | Letter from the SEC | Oct 11, 2019 | — |
| EFFECT | Filing | Jul 18, 2019 | — |
| CORRESP | Letter to the SEC | Jul 16, 2019 | — |
| CORRESP | Letter to the SEC | Jul 16, 2019 | — |
| EFFECT | Filing | Jun 21, 2019 | — |
| EFFECT | Filing | Jun 21, 2019 | — |
| CORRESP | Letter to the SEC | Jun 19, 2019 | — |
| CORRESP | Letter to the SEC | Jun 19, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 19, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 19, 2019 | — |
| RW | Filing | Jun 4, 2019 | — |
| UPLOAD | Letter from the SEC | May 17, 2019 | — |
| NT 10-Q | Filing | May 15, 2019 | Mar 31, 2019 |
| UPLOAD | Letter from the SEC | Apr 30, 2019 | — |
| CORRESP | Letter to the SEC | Apr 23, 2019 | — |
| PRER14A | Filing | Apr 23, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 19, 2019 | — |
| CORRESP | Letter to the SEC | Apr 9, 2019 | — |
| PRER14A | Filing | Apr 9, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 4, 2019 | — |
| D | Filing | Apr 3, 2019 | — |
| NT 10-K | Filing | Apr 1, 2019 | Dec 31, 2018 |
| NT 10-Q | Filing | Nov 15, 2018 | Sep 30, 2018 |
| EFFECT | Filing | Oct 1, 2018 | — |
| CORRESP | Letter to the SEC | Sep 28, 2018 | — |
| CORRESP | Letter to the SEC | Sep 28, 2018 | — |
| D | Filing | Sep 27, 2018 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2018 | — |
| D | Filing | Sep 24, 2018 | — |
| CT ORDER | Filing | Aug 31, 2018 | — |
| EFFECT | Filing | May 1, 2018 | — |
| EFFECT | Filing | Apr 27, 2018 | — |
| CORRESP | Letter to the SEC | Apr 27, 2018 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2018 | — |
| CORRESP | Letter to the SEC | Apr 25, 2018 | — |
| CORRESP | Letter to the SEC | Apr 12, 2018 | — |
| NT 10-K | Filing | Apr 2, 2018 | Dec 31, 2017 |
| D | Filing | Apr 2, 2018 | — |
| D | Filing | Apr 2, 2018 | — |
| D | Filing | Apr 2, 2018 | — |
| D | Filing | Apr 2, 2018 | — |
| D | Filing | Mar 30, 2018 | — |
| D | Filing | Mar 30, 2018 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2018 | — |
| CORRESP | Letter to the SEC | Feb 23, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 15, 2018 | — |
| CORRESP | Letter to the SEC | Feb 13, 2018 | — |
| PRER14A | Filing | Feb 13, 2018 | — |
| EFFECT | Filing | Feb 12, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 12, 2018 | — |
| CORRESP | Letter to the SEC | Feb 9, 2018 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2018 | — |
| D | Filing | Jan 11, 2018 | — |
| NT 10-Q | Filing | Nov 15, 2017 | Sep 30, 2017 |
| EFFECT | Filing | Nov 6, 2017 | — |
| CORRESP | Letter to the SEC | Nov 3, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 30, 2017 | — |
| UPLOAD | Letter from the SEC | Oct 6, 2017 | — |
| CORRESP | Letter to the SEC | Sep 20, 2017 | — |
| EFFECT | Filing | Sep 14, 2017 | — |
| CORRESP | Letter to the SEC | Sep 13, 2017 | — |
| UPLOAD | Letter from the SEC | Sep 12, 2017 | — |
| CORRESP | Letter to the SEC | Sep 12, 2017 | — |
| D | Filing | Aug 30, 2017 | — |
| UPLOAD | Letter from the SEC | Aug 25, 2017 | — |
| CT ORDER | Filing | Jul 11, 2017 | — |
| 425 | 8-k | Jul 7, 2017 | — |
| EFFECT | Filing | Jul 6, 2017 | — |
| UPLOAD | Letter from the SEC | Jul 6, 2017 | — |
| CORRESP | Letter to the SEC | Jul 5, 2017 | — |
| CORRESP | Letter to the SEC | Jun 30, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 30, 2017 | — |
| CORRESP | Letter to the SEC | Jun 23, 2017 | — |
| UPLOAD | Letter from the SEC | Jun 9, 2017 | — |
| 425 | Filing | Jun 7, 2017 | — |
| CORRESP | Letter to the SEC | May 26, 2017 | — |
| UPLOAD | Letter from the SEC | May 15, 2017 | — |
| 425 | 8-k | Apr 6, 2017 | — |
| 425 | 8-k | Mar 31, 2017 | — |
| CT ORDER | Filing | Mar 15, 2017 | — |
| 425 | Filing | Feb 21, 2017 | — |
| 425 | 8-k | Feb 9, 2017 | — |
| EFFECT | Filing | Dec 19, 2016 | — |
| UPLOAD | Letter from the SEC | Dec 19, 2016 | — |
| CORRESP | Letter to the SEC | Dec 16, 2016 | — |
| 425 | 8-k | Oct 6, 2016 | — |
| EFFECT | Filing | Oct 5, 2016 | — |
| EFFECT | Filing | Jul 8, 2016 | — |
| CORRESP | Letter to the SEC | Jul 7, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 1, 2016 | — |
Showing 167 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- JAGX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1585608
- Former names
- Jaguar Animal Health, Inc. (until Jul 31, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.